U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762287) titled 'Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants' on July 15.
Brief Summary: This study is being done to compare two forms of the medicine elinzanetant, which is used to help manage hot flush symptoms related to changes in female hormones. The researchers want to find out whether a new tablet form of elinzanetant is absorbed and processed by the body of healthy women in a similar way than an existing capsule form.
About 100 healthy women aged 18 to 65 will take part in this study. Each participant will receive both forms of the medicine at different times during the ...